Marston, M, et al.
Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. International Journal of Epidemiology
2011; 40: 385–396.
Modi, S, et al.
Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings. AIDS
2013; 27 (Suppl. 2): S159–167.
National Department of Health of South Africa. HIV & AIDS and STI strategic plan for South Africa: 2007–2011. Pretoria: Department of Health, 2007.
Sanne, I, et al.
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet
2010; 376: 33–40.
Nyasulu, JC, et al.
NIMART rollout to primary healthcare facilities increases access to antiretrovirals in Johannesburg: an interrupted time series analysis. South African Medical Journal
2013; 103: 232–236.
Penazzato, M, et al.
Task shifting for the delivery of pediatric antiretroviral treatment: a systematic review. Journal of Acquired Immune Deficiency Syndromes
2014; 65: 414–422.
National Department of Health of South Africa. National antiretroviral treatment guidelines. Pretoria: Department of Health, 2004.
National Department of Health of South Africa. Guidelines for the management of HIV in children. Pretoria: Department of Health, 2010.
National Department of Health of South Africa. Initiation of anti retroviral treatment (ART) to all HIV positive children aged 5 years and under regardless of CD4 count and/or WHO clinical staging (Circular minute No. 2 of 2012). Pretoria, 20 August 2012.
National Department of Health of South Africa. The South African antiretroviral treatment guidelines. Pretoria: Department of Health, 2013.
Osler, M, et al.
A three-tier framework for monitoring antiretroviral therapy in high HIV burden settings. Journal of the International AIDS Society
2014; 17: 18908.
National Department of Health of South Africa. The 2013 national antenatal sentinel HIV prevalence survey South Africa. Pretoria: Department of Health, 2015.
National Department of Health of South Africa. National consolidated guidelines for the prevention of mother-to-child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. Pretoria: Department of Health, 2014.
Sherman, GG, et al.
Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa. South African Medical Journal
2014; 104: 235–238.
Eley, B, et al.
Antiretroviral treatment for children. South African Medical Journal
2006; 96: 988–993.
Davies, MA, et al.
Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration. South African Medical Journal
2009; 99: 730–737.
Grimwood, A, et al.
Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa. Journal of the International AIDS Society
2012; 15: 17381.
Kids-Art-Linc Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. Journal of Acquired Immune Deficiency Syndromes
2008; 49: 523–531.
Porter, M, et al.
Outcomes of infants starting antiretroviral therapy in Southern Africa, 2004–2012. Journal of Acquired Immune Deficiency Syndromes
2015; 69: 593–601.
Weigel, R, et al.
Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC Infectious Diseases
2011; 11: 31.
Boulle, A, et al.
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS
2010; 24: 563–572.
Cornell, M, et al.
Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002–2007. AIDS
2010; 24: 2263–2270.
Fatti, G, Grimwood, A, Bock, P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS ONE
2010; 5: e12888.
Meloni, ST, et al.
Time-dependent predictors of loss to follow-up in a large HIV treatment cohort in Nigeria. Open Forum Infectious Diseases
2014; 1: ofu055.
Ekouevi, DK, et al.
12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000–2008. BMC Public Health
2011; 11: 519.
Grimsrud, A, et al.
Outcomes of antiretroviral therapy over a 10-year period of expansion: a multicohort analysis of African and Asian HIV programs. Journal of Acquired Immune Deficiency Syndromes
2014; 67: e55–66.
Houle, B, et al.
The unfolding counter-transition in rural South Africa: mortality and cause of death, 1994–2009. PLoS ONE
2014; 9: e100420.
Jones, SA, Sherman, GG, Varga, CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg, South Africa. AIDS Care
2005; 17: 466–470.
Weigel, R, et al.
Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS
2012; 26: 365–373.
Kelly, D, Coutts, AG. Early nutrition and the development of immune function in the neonate. The Proceedings of the Nutrition Society
2000; 59: 177–185.
Davies, MA, et al.
Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatrics
2008; 8: 34.
Technau, KG, et al.
Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children. Pediatric Infectious Disease Journal
2013; 32: 851–855.
Technau, KG, et al.
Virologic response in children treated with abacavir-compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis. Pediatric Infectious Disease Journal
2014; 33: 617–622.
Waters, LJ, et al.
Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients. Antiviral Therapy
2007; 12: 825–830.
Takuva, S, et al.
Disparities in engagement within HIV care in South Africa [Abstract 154]. Conference on Retroviruses and Opportunistic Infections. Seattle, Washington: 23–26 February 2015.
Violari, A, et al.
Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine
2008; 359: 2233–2244.
Fatti, G, et al.
Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa. AIDS Care
2014; 26: 448–453.
Bernheimer, JM, et al.
Paediatric HIV treatment failure: a silent epidemic. Journal of the International AIDS Society
2015; 18: 20090.